Skip to main content
logo
Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.6915
-0.0335 (-4.62%)
Sep 1, 2026, 4:00 PM EDT - Market closed

Estrella Immunopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Jun '24 Jun '23 Jun '22
Market Capitalization
3059433819-
Market Cap Growth
-22.71%35.70%13.67%101.23%--
Enterprise Value
3057423321-
Last Close Price
0.691.561.201.0510.8410.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Jun '24 Jun '23 Jun '22
PB Ratio
--5.68302.068.94-2.81-
P/TBV Ratio
--302.068.94--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
-0.000.030.000.00-
Net Debt / Equity Ratio
0.020.13-6.35-0.970.36-1.03
Quick Ratio
0.020.100.3123.050.254.32
Current Ratio
0.200.120.5524.650.285.20
Return on Assets (ROA)
-251.86%-258.45%--122.12%-174.75%-
Return on Capital Employed (ROCE)
130.30%126.00%-6154.50%-171.10%165.20%-42.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Jun '24 Jun '23 Jun '22
Earnings Yield
-33.29%-22.17%-20.38%-19.14%-58.56%-
Buyback Yield / Dilution
-10.44%-1.63%-33.68%-8764.81%--
SEC Filings: 10-K · 10-Q